Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease

被引：3

作者：

Hussein, Ayman A. ^{[1
]}

Alvarez, Paulino ^{[2
]}

Reed, Grant ^{[3
]}

Heresi, Gustavo A. ^{[4
]}

机构：

[1] Cleveland Clin, Dept Cardiovasc Med, Sect Cardiac Pacing & Electrophysiol, Cleveland, OH 44106 USA

[2] Cleveland Clin, Sect Heart Failure, Dept Cardiovasc Med, Cleveland, OH 44106 USA

[3] Cleveland Clin, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44106 USA

[4] Cleveland Clin, Dept Pulm & Crit Care Med, Cleveland, OH 44106 USA

来源：

CHEST | 2022年 / 161卷 / 05期

关键词：

direct oral anticoagulant; off-label use; thromboembolism; VALVULAR HEART-DISEASE; ATRIAL-FIBRILLATION; PULMONARY-HYPERTENSION; SINUS RHYTHM; ANTITHROMBOTIC THERAPY; VALVE THROMBOSIS; WARFARIN; FAILURE; OUTCOMES; STROKE;

D O I：

10.1016/j.chest.2022.01.033

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Direct oral anticoagulants (DOACs) are increasingly used in clinical practice and have become essential in the management of atrial fibrillation and VTE. The enthusiasm for DOACs has fueled the off-label application of these agents in cardiopulmonary disease, and their use has often outpaced the evidence supporting their application. This article reviews the evidence and current off-label use of DOACs in various cardiopulmonary disease states.

引用

页码：1360 / 1369

页数：10

共 50 条

[41] Newer Anticoagulants Can Be Used Off-Label
Choi, Philip M. C.
Hill, Michael D.
[J]. STROKE, 2014, 45 (07) : 2154 - 2155
[42] Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants
Puia-Dumitrescu, Mihai
Smith, P. Brian
Zhao, Jian
Soriano, Angela
Payne, Elizabeth H.
Harper, Barrie
Bendel-Stenzel, Ellen
Moya, Fernando
Chhabra, Rakesh
Ku, Lawrence
Laughon, Matthew
Wade, Kelly C.
Furda, Gary
Benjamin, Danny
Capparelli, Edmund
Kearns, Gregory L.
Paul, Ian M.
Hornik, Christoph
[J]. JOURNAL OF PEDIATRICS, 2019, 211 : 27 - +
[43] Dosing considerations in the use of the direct oral anticoagulants in the antiphospholipid syndrome
Schofield, J. R.
Hassell, K.
[J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (01) : 104 - 106
[44] Off-label use in cardiac surgery ["Off-label use" in der Herzchirurgie]
Fenger H.
Löher A.
Sindermann J.R.
Scheld H.H.
Schmidt C.
Hoffmeier A.
[J]. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2009, 23 (6) : 345 - 348
[45] An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation
Shen, Nan-Nan
Ferroni, Eliana
Amidei, Claudio Barbiellini
Canova, Cristina
Peron, Viviana
Wang, Jia-Liang
Lin, Hou-Wen
Gu, Zhi-Chun
[J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
[46] Characteristics and Outcomes in Patients With Atrial Fibrillation (af) Receiving Direct Oral Anticoagulants (doacs) in off-Label Dose.
Sarrazin, Vaughan Mary S.
Briasoulis, Alexandros
Leira, Enrique C.
[J]. STROKE, 2019, 50
[47] Inappropriate Off-label Use of a Qualitative, Point-of-care hCG Device
Nerenz, Robert D.
Gronowski, Ann M.
Grenache, David G.
[J]. WESTERN JOURNAL OF EMERGENCY MEDICINE, 2017, 18 (02) : 324 - 325
[48] Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use
Rodwin, Marc A.
[J]. JOURNAL OF LAW MEDICINE & ETHICS, 2013, 41 (03): : 654 - 664
[49] Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes The ORBIT-AF II Registry
Steinberg, Benjamin A.
Shrader, Peter
Thomas, Laine
Ansell, Jack
Fonarow, Gregg C.
Gersh, Bernard J.
Kowey, Peter R.
Mahaffey, Kenneth W.
Naccarelli, Gerald
Reiffel, James
Singer, Daniel E.
Peterson, Eric D.
Piccini, Jonathan P.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (24) : 2597 - 2604
[50] Off-label use and G-BA. Legal framework for off-label use
Brucklacher, U.
Brockmeyer, N. H.
Riedel, C.
[J]. HAUTARZT, 2013, 64 (10): : 736 - 742

← 1 2 3 4 5 →